We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.00 | 0.55% | 1,645.00 | 1,644.50 | 1,645.00 | 1,650.00 | 1,635.00 | 1,642.00 | 516,172 | 09:18:34 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 3915N
GlaxoSmithKline PLC
15 May 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) I give details of changes in the interests of Mr S Dingemans, an Executive Director, in the Ordinary Shares of GlaxoSmithKline plc (the "Company").
The Company was advised on 15 May 2015 that Mr S Dingemans transferred 40,000 Ordinary Shares held under a personal shareholding account to a Corporate Sponsored Nominee on 14 May 2015.
V A Whyte
Company Secretary
15 May 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQELFFEEFFBBE
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
